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Purpose: To determine enzymatic antioxidant and lipid peroxidation levels in seminal 
plasma of patients orchiectomized for testicular tumors.
Materials and Methods: The study included 52 patients: 26 control men and 26 orchi-
ectomized patients for testicular tumor, of which 12 men had seminoma tumor and 
14 men non-seminoma tumor. After semen analysis performed according to the WHO 
guidelines, an aliquot of semen was centrifuged and the seminal plasma was collected. 
Lipid peroxidation was performed by thiobarbituric acid reactive substances (TBARS) 
assay and antioxidant profile was assessed by analyzing catalase, glutathione per-
oxidase (GPx) and superoxide anion (SOD) activities using colorimetric assays with a 
standard spectrophotometer. Data were tested for normality and compared using one-
way ANOVA (p<0.05).
Results: Seminoma and non-seminoma groups presented lower sperm concentration 
and morphology when compared to control group (p=0.0001). Both study groups (sem-
inoma and non-seminoma) presented higher TBARS levels when compared to con-
trol group (p=0.0000013). No differences were observed for SOD (p=0.646) andGPx 
(p=0.328). It was not possible to access the enzymatic activity of catalase in any group.
Conclusion: Patients with testicular tumor present increased semen oxidative stress, 
but no differences were observed in antioxidant levels, even after orchiectomy. This 
indicates that most likely an increased generation of oxidative products takes place in 
these patients.
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InTRODucTIOn
Testicular tumors account for about 1 to 
2% of all kinds of tumors that affect men, cau-
sing approximately 0.1% of deaths from cancers 
in men (1-3). In Brazil, in 2013, the National Ins-
titute of Cancer (INCA) estimated approximately 
343 deaths caused by testicular cancer (4).
 Histologically, testicular tumors are divi-
ded into germ cell (95% of cases) and non-germ 
cell tumors (5% of cases) (5). Germ cell tumors 
are further divided into seminoma (60% of cases) 
and non-seminoma (40% of cases) (5-7). Semino-
mas are more frequent in men about 40 years old, 
while non-seminomas are more frequent in men 
between 20-35 years old (5, 8, 9).
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 The treatment for patients with a testi-
cular tumor is orchiectomy of the affected testis 
via inguinal surgery, followed, in most cases, by 
adjuvant treatments such as chemotherapy, and/
or radiotherapy, and/or retroperitoneal lymphade-
nectomy (10, 11). Although unilateral orchiectomy 
does not result directly in infertility, because the 
remaining testicle may present normal sperma-
togenesis, potential side effects are disruption of 
retroperitoneal sympathetic nerves, which may re-
sult in retrograde ejaculation (12), and a high risk 
of hypogonadotropic hypogonadismdue to the re-
duction in testosterone production (13).
 Regardless of their classification, studies 
have reported the association of testicular tumors 
with testicular oxidative imbalance (14, 15) whi-
ch can compromise sperm motility, concentration, 
and morphology, as well as interfere with sperm 
capacitation and fertilization (16-18). The semi-
nal plasma, however, represents the main protec-
tion system, which includes a chain of enzymatic 
antioxidants, composed by superoxide dismutase 
(SOD), catalase (CAT) and glutathione peroxidase 
(GPx), which are capable of neutralizing ROS, thus 
preventing damage caused by oxidative stress (19).
 Although it is well known that testicular 
tumors are harmful to the sperm membrane (20), 
it still remains to be clarified if orchiectomized pa-
tients return to a normal state after the surgery, or 
if oxidative stress is still present. Therefore, this 
study set out to investigate the enzymatic antio-
xidant profile and lipid peroxidation products in 
seminal samples of patients with testicular germ 
cell tumors after orchiectomy.
MATERIALs AnD METhODs
Study design and patients
 A cross-sectional study was performed 
with 52 men between 18-45 years old. The stu-
dy groups comprised patients referred for semen 
cryopreservation at the Cell and Germinative Tis-
sue Bank in the Federal University of São Paulo. 
The study groups included 12 patients orchiecto-
mized for a unilateral seminoma testicular germ 
cell tumor (study group S) and 14 patients orchiec-
tomized for a unilateral non-seminoma testicular 
germ cell tumor (study group NS), which did not 
present post-operative complications after the 
surgery. The semen collection was realized one 
month after surgery, before the beginning of any 
adjuvant therapy. The control group was com-
posed of 26 healthy men without testicular germ 
cell tumor and semen quality within the 95% 
fertile range of the 2010 World Health Organiza-
tion (WHO) guidelines (21), seeking the Human 
Reproduction Sector, Division of Urology, Sao 
Paulo Federal University Andrology Laboratory 
for semen analysis. Patients referring fever in 
the 90 days period prior to semen analysis, with 
evidence of urogenital infection, and patients 
with a history of cancer or endocrinophaties (and 
their treatments), smokers, individuals with BMI 
≥30 and individuals who had not yet been sub-
mitted to orchiectomy were excluded from the 
study. Institutional Review Board approval was 
obtained from the Sao Paulo Federal University 
Research Ethics Committee.
Semen analysis
 Semen samples were obtained by mastur-
bation after 2 to 5 days of ejaculatory abstinence. 
After liquefaction, semen analysis was conducted 
according to the WHO guidelines (21). Immediate-
ly after the semen analysis, 0.5mL was centrifuged 
at 16.000g for 1h at 4ºC to remove all the cellular 
debris. The supernatant seminal plasma was then 
collected and stored at -20ºC until the time of the 
analyses. All of the remaining semen volume was 
transported to the Germ Cell and Tissue Bank of 
the Human Reproduction Sector / Division of Uro-
logy of the Sao Paulo Federal University for cryo-
preservation (22).
Lipid Peroxidation assessment
 Lipid peroxidation was determined with 
the method described by Ohkawa et al. (23), whi-
ch is based on the determination of its products, 
mainly the malondialdehyde (MDA) levels, due 
to its reaction with thiobarbituric acid (TBA). To 
precipitate proteins, 500μL of seminal plasma and 
1000μL of a 10% solution (v:v) of trichloroace-
tic acid (TCA 10%) were mixed and centrifuged 
(18.000 x g for 15 min at 15ºC). After centrifu-
gation, 500μL of the supernatant and 500μL of 
1% (v:v) thiobarbituric acid (TBA, 1%), in 0.05N 
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sodium hydroxide in glass tubes were placed into 
a boiling water bath (100ºC) for 10 min, and sub-
sequently cooled in an ice bath (0ºC) to stop the 
chemical reaction. The TBARS were then quanti-
fied using a spectrophotometer (UV-vis Spectro-
photometer Ultrospec 3300 Pro; BiochromLtd., 
Cambridge, UK) at a wave length of 532nm. The 
results were compared with a previously prepared 
standard curve with a standard solution of ma-
londialdehyde (Sigma-10.838-3-St Louis, USA). 
Lipid peroxidation levels were described in nano-
grams of TBARS/mL of seminal plasma. TBARS le-
vels were then normalized to sperm concentration 
(TBARS/sperm).
Antioxidant seminal profile
 Catalase activity was determined indi-
rectly through monitoring hydrogen peroxide 
consumption (H2O2). The reaction solution con-
tained 10μL of seminal plasma added to 90μL of 
Tris(hydroxymethyl)-amino-methane/EDTA bu-
ffer solution (50 and 250mM, respectively) and 
900μL of H2O2 (9.0mM). The reaction was allowed 
to take place at pH 8.0, 30ºC, for 8 min, and then 
the enzymatic activity was measured using a spec-
trophotometer (wavelength, 230nm). The absor-
bance was measured every 5 seconds, generating 
a curve of H2O2 consumption that was compared 
with a blank sample. The calculations considered 
the value 0.071M-1 x cm-1 as a molar extinction 
coefficient of H2O2. The activity of the enzyme ca-
talase was calculated based on the formula [ca-
talase activity=(initial absorbance-final absorban-
ce)/0.071 x dilution] and the result expressed in 
UI/mL (24).
 The enzymatic activity of the Glutathione 
peroxidase(GPx) was determined indirectly by me-
asuring the consumption of reduced nicotinamide 
adenine dinucleotide phosphate (NADPH) (24). 
The assay mixture consisted of NADPH (0.12mM, 
1mL), GSH (1mM, 100mL), GSSGr (0.25U/mL, 
20mL), and sodium azide (0.25mM, 20mL). A vo-
lume of 100μL of seminal plasma was used. The 
spectrophotometer cell was brought up to a volu-
me of 1.9mL with phosphate buffer 143mM, EDTA 
6.3mM, (pH 7.5), that was also used to dissolve the 
NADPH. The GSH was dissolved in 5% metaphos-
phoric acid. Sodium azide was used to inhibit the 
action of catalase. This reaction was initiated with 
the addition of 1.2mM of tert-butyl hydro pero-
xide (TBHP, 100mL), and the consumption of NA-
DPH was detected at a wavelength of 340nm, for 
10 min at 37oC (measurements performed every 5 
seconds). The results of GSH-Px were expressed as 
units of GSH-Px/mL of semen, and calculations 
used 6.22mM-1 x cm-1 as the extinction coeffi-
cient of NADPH (24).
 The SOD activity was measured indirectly 
by means of the reduction rate of cytochrome C 
by superoxide anion (O2-) controlled every 5 min. 
The xanthine-xanthine oxidase system was used 
as a continuous generated of O2- that, in turn, 
causes the reduction of cytochrome C. The total 
SOD in seminal sample competes with cytochro-
me C and superoxide anion (O2-). The total SOD 
activity was measured indirectly by determining 
the decrease rate in the reduction of cytochrome C 
(Floré & Otting, 1984). The assay mixture consis-
ted of 10μL of seminal plasma, 835μL of a solution 
containing cytochrome C (1mM) and xanthine 
(50mM), and 155μL of xanthine oxidase diluted in 
sodium phosphate/EDTA buffer (50 and 100mM, 
respectively, pH 7.8). The concentration of xan-
thine oxidase was calculated to generate the op-
timum amount of O2 with a consequent reduction 
of cytochrome C that was calculated as the rate of 
cytochrome C reduction of 0.025 units of absor-
bance/min (at 550nm of wavelength); the basis of 
this calculation is that 1 unit of total SOD activity 
corresponded to 50% of this value. Therefore, SOD 
activity in the sample decreased the rate of cyto-
chrome reduction when compared to the blank.
statistical analysis
 The data were analyzed in the SAS Sys-
tem for Windowssoftware (SAS, 2000). The ap-
plicative Guided Data Analysis was used to test 
the data for residue normality (normal distribu-
tion) and homogeneity of variances. If normali-
ty was not observed, variables were transformed 
into their logarithmic or square root values. If 
after transformation normality was not observed, 
a non-parametric analysis was carried out using 
theNPAR1WAY procedure. For data with normal 
distribution, the ANOVA test followed bya Least 
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Significant Differences (LSD) post-hoc test was 
used to compare the groups. An α of 5% was con-
sidered for all the analyses.
REsuLTs
 Individual characteristics and semen qua-
lity results are presented in Table-1. No statisti-
cally significant differences were observed in age, 
ejaculate volume, sperm motility, and round cells 
and neutrophil concentration between the three 
groups. The seminoma and non-seminoma pre-
sented lower sperm concentration, morphology, 
and total sperm count when compared to the con-
trol group.
 The variables TBARS, GPx, SOD and 
TBARS/sperm of the three groups (seminoma, 
non-seminoma, and control) are shown in Ta-
ble-2. The seminoma and non-seminoma groups 
presented higher TBARS levels when compared 
to controls. No statistically significant differen-
ces were observed for SOD and GPx activities. No 
reading levels were achieved for catalase enzyme 
activity by the Beutler method in any group.
DIscussIOn
 Whichever the histological origin of the 
testicular germ cell tumor (seminoma or non-se-
minoma), orchiectomy is the initial therapeutic ap-
proach, usually followed by gonadotoxic adjuvant 
therapies, such as chemotherapy and radiotherapy 
(25). However, even before any treatment for the 
cancer begins, patients may display reduced fertili-
ty potential because of alterations to the testicular 
environment due to the disease itself (14, 15).
 To our knowledge, there is no study in the 
literature that evaluates the role of oxidative stress 
and antioxidants in the seminal plasma of testi-
cular germ cell tumor patients after orchiectomy. 
Thus, this study aimed to verify the activity of the 
main seminal antioxidant enzymes SOD, GPx, and 
catalase as well as the oxidative by-product ma-
londialdehyde. The seminal non-enzymatic antio-
xidant milieu consists of GPx, SOD and catalase 
to physiologically control the balance between 
ROS production and neutralization (26). In this 
study, catalase levels were undetected. However, 
determining catalase activity in seminal plasma 
remains a matter of debate, because the presence 
of this antioxidant in the semen is usually due 
mainly to the presence of neutrophils (24).Because 
the semen of our patients presented low concen-
tration of these cells (under 0.5million/mL in ei-
ther group), this could explain why catalase was 
not detected in this study.
 GPx protects sperm membrane from oxi-
dative stress and is involved in redox regulation 
(27). In addition, SOD is responsible for dismuta-
tion of superoxide radicals (O2-)into H2O2 and O2 
(28). Regarding the seminoma and non-seminoma 
groups,when compared to healthy control men, 
no differences were observed in the SOD and GPx 
activity, suggesting that antioxidant mechanisms 
were not altered in the presence of a testicular 
germ cell tumor followed by orchiectomy. This 
may stem from the fact that most of the seminal 
antioxidant levels is supported by secretions from 
the prostate and seminal vesicles (27, 28), which 
are apparently unaffected by the presence of a tes-
ticular cancer, at least in terms of their production 
of enzymatic antioxidants. It could be argued that 
epididymal antioxidants also contribute to the se-
minal antioxidant capacity, but their contribution 
is generally described as much lower (29), and it 
is still not known whether epididymal secretion of 
antioxidants is affected by the tumor.
 However, even with unchanged levels of 
antioxidants, sperm from patients of the semi-
noma and non-seminoma groups showed greatly 
increased sensibility to oxidative damage - de-
monstrated by increased TBARS levels normali-
zed to sperm concentration -when compared to 
controls. Besides the mean looks different by the 
observer, this study did not observe statistical di-
fference in TBARS/sperm of seminoma vs. non-
-seminoma patients.The cancer itself causes an 
increase in ROS levels (30), which may be mainly 
due to: (i) increased metabolic activity and energy 
produced by mitochondria (30) and (ii) chronic in-
flammation and cytokine releasing (31).Moreover, 
the presence of a testicular cancer may produce 
an inflammatory state in the contralateral testis 
(31), which in turn may lead to delayed sperma-
togenesis, thus increasing the production of im-
mature sperm (20). This sperm-centered oxidative 
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Table 1 - semen analysis of orquiectomized men and healthy control men. Groups were compared by AnOvA followed by 
LsD post-hoc test.
Control Group
(n= 26)
Seminoma Group
(n= 12)
Non-Seminona Group
(n= 14)
p
Age (years)
Mean; SD 29.8; 3.27 28.4; 6.02 26.7; 6.17 0.165
95% CI [28.56; 31.21] [24.59; 32.24] [23.22; 30.35]
Abstinence (days)
Mean; SD 4.4; 3.47 6.7; 7.44 5.3; 6.00 0.993
95% CI [3.06; 5.87] [2.02; 11.48] [1.89; 8.83]
volume (mL)
Mean; SD 3.6; 0.97 3.8; 1.73 3.2; 1.30 0.478
95% CI [3.23; 4.02] [2.76; 4.96] [2.45; 4.02]
progressive motility (%)
Mean; SD 56.6; 7.05 63.1; 6.43 58.2; 9.80 0.098
95% CI [53.84; 59.54] [58.49; 67.70] [52.63; 63.94]
non-progressive motility (%)
Mean; SD 4.5; 1.98 3.8; 2.35 5.0; 2.09 0.340
95% CI [3.70; 5.30] [2.02; 5.40] [3.86; 6.28]
sperm concentration (X106/mL)
Mean; SD 82.4; 53.48b 18.1; 23.06a 16.7; 17.26a <0.0001*
95% CI [60.82; 104.02] [2.69; 33.68] [6.79; 26.73]
Total sperm count (X106)
Mean; SD 295.7; 213.03b 59.6; 72.82a 69.6; 85.70a <0.0001*
95% CI [209.73; 381.82] [13.36; 105.89] [20.14; 119.11]
Morphology (% normal)
Mean; SD 14.4; 0.85b 5.0; 3.22a 5.4; 2.06a <0.0001*
95% CI [14.11; 14.81] [2.97; 7.06] [4.24; 6.62]
Round cells (X106/mL)
Mean; SD 0.9; 0.74 0.7; 1.08 1.3; 0.97 0.304
95% CI [0.68; 1.28] [0.07; 1.45] [0.74; 1.86]
neutrophils (X106/mL)
Mean; SD 0.1; 0.17 0.1; 0.18 0.2; 0.50 0.577
95% CI [0.04; 0.18] [-0.02; 0.22] [-0.09; 0.50]
sD=Standard deviation
95% cI =Confidence interval of 95% of the mean
* – significant difference 
Different Letters in the same row indicate significant difference (post-hoc LSD test – p<0.05).
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Table 2- TBARs, Glutathione peroxidase (Gpx) and superoxide Dismutase (sOD) levels from orquiectomized men and 
healthy control men. Groups were compared by AnOvA followed by LsD post-hoc test.
Control Group
(n= 26)
Seminoma Group
(n=12)
Non-seminoma Group
(n=14)
p
TBARs/sperm
Mean; SD 3.2; 2.59b 53.2; 127.19a 22.7; 25.95a <0.001*
95% CI [2.16; 4.26] [-27.62; 134.01] [7.74; 37.71]
Gpx (uI/mL)
Mean; SD 65.0; 20.02 59.9; 19.45 67.5; 23.05 0.646
95% CI [56.97; 73.15] [47.63; 72.35] [54.21; 80.83]
sOD (uI/mL)
Mean; SD 63.9; 59.84 34.3; 30.64 50.0; 27.49 0.328
95% CI [39.79; 88.13] [14.88; 53.83] [34.16; 65.92]
sD=Standard deviation
95% cI=Confidence interval of 95% of the mean
* – significant difference 
Different Letters in the same row indicate significant difference (post-hoc LSD test – p<0.05).
stress (as demonstrated by our results) would ex-
plain why lipid peroxidation levels would depend 
on sperm concentration - the latter acting as a 
substrate for the former (32). Given that,in our 
study, testicular germ cell tumor patients collec-
ted semen samples on average one month after 
orchiectomy,the inflammatory state would not 
have had time to be fully resolved, as one full 
cycle of spermatogenesis would not have yet oc-
curred. This is further supported by the fact that 
the study group presented decreased sperm con-
centration (quantity) and morphology (quality).
The findings corroborate with Tavilani et al. (33) 
study, which observed antioxidant profile and 
oxidative stress in asthenozoospermic men and 
only observed a significant difference in TBARS/
sperm, indicating that the mechanism of oxida-
tive stress occurs similarly in infertile men and 
testicular germ-cell tumor patients.
 Besides, this study is limited to the fact 
that the patients have a short period to perform 
a sample collection, because after they are sub-
mitted to orchiectomy, the adjuvant therapy is 
required. This way, it is not possible to observe 
antioxidant profile difference after a complete 
spermatogenesis cycle. In addition, the number of 
patients included in the study could not be enou-
gh to demonstrate difference in some studied pa-
rameters. Moreover, a further path for future rese-
arch would be increase the number of patients and 
include pre-operative samples, which would add 
information regarding how the antioxidants and 
lipid peroxidation act in a tumor milieu.
cOncLusIOns
 In short, we verified that there is an im-
balance on lipid peroxidation in patients with 
testicular germ cell tumors when compared with 
healthy individuals. Therefore, patients with se-
minoma and non-seminoma tumors demonstrated 
an increased seminal oxidative stress. Also, the-
re was no difference in antioxidant levels, after 
orchiectomy. This seminal increase in oxidative 
stress is attributed to increased ROS generation 
caused by the tumor itself. In conclusion, orchiec-
tomized patients, when compared to healthy con-
trols, do not differ in terms of enzymatic antioxi-
dant levels, but present lower semen quality and 
increased sperm-centered oxidative stress.
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